Related Experiment Video
Updated: Oct 19, 2025
07:07
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
10.8K
Seizure after recovery from Covid-19
Sidhartha Chattopadhyay1, Sagar Basu1, Kamalesh Majumdar2
1Department of Neuro-Medicine, KPC Medical College and Hospital, Kolkata, West Bengal, India.
Journal of Family Medicine and Primary Care
|September 27, 2021
Summary
A young woman experienced a first-time seizure 14 days post-SARS-CoV-2 infection. Neurological imaging revealed focal cerebritis, which resolved with anti-epileptic treatment, highlighting a potential COVID-19 neurological complication.
Area of Science:
- Neurology
- Infectious Diseases
- Neuroscience
Background:
- Neurological complications of COVID-19 are diverse.
- Seizures represent a significant neurological manifestation.
- Understanding the link between SARS-CoV-2 and new-onset epilepsy is crucial.
Observation:
- A 27-year-old female with no prior seizure history presented with a generalized tonic-clonic seizure.
- The seizure occurred 14 days after a documented SARS-CoV-2 infection.
- The patient had a history of generalized anxiety disorder managed with SSRI.
Findings:
- Electroencephalogram (EEG) indicated post-ictal discharges.
- Magnetic Resonance Imaging (MRI) of the brain revealed focal cerebritis in both frontal lobes.
- The patient was treated with anti-epileptic drugs.
Implications:
- This case suggests a potential link between SARS-CoV-2 infection and new-onset seizures.
- Focal cerebritis may be a neurological consequence of COVID-19.
- Prompt anti-epileptic treatment led to complete resolution of EEG and MRI abnormalities, indicating potential for recovery.
More Related Videos
Related Concept Videos
01:13Seizures: Classification
685
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
685
01:24Epilepsy and Seizures: Overview
367
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
367
01:20Antiepileptic Drugs: Potassium Channel Activators
363
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
363
01:30Electroconvulsive Therapy
266
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
266
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
526
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
526
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
806
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
806